Minerva Urology and Nephrology 2022 October;74(5):642-6

DOI: 10.23736/S2724-6051.22.04959-X

lingua: Inglese

Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer

Fabrizio DI MAIDA ¹, Antonio A. GROSSO ¹, Riccardo TELLINI ¹, Luca LAMBERTINI ¹, Mattia LO RE ¹, Anna CADENAR ¹, Sofia GIUDICI ¹, Roberta GIORGIONE ², Virginia ROSSI ², Lorenzo ANTONUZZO ², Andrea MINERVINI ¹, Andrea MARI ¹ ✉

¹ Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy; ² Unit of Medical Oncology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy

HTML PDF

inizio pagina

I TUOI DATI

I TUOI ORDINI

CESTINO ACQUISTI

COME ORDINARE

I TUOI ABBONAMENTI

I TUOI ARTICOLI

I TUOI EBOOK

COUPON

ACCESSIBILITÀ

Minerva Urology and Nephrology 2022 October;74(5):642-6

Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer

Publication History

Per citare questo articolo

Corresponding author e-mail

Share